Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder

Keyphrases

• Treatment as Usual 100%
• Opioid Use Disorder 100%
• Cost-utility 100%
• Prescription Digital Therapeutic 100%
• Health Utility 42%
• Clinical Trials 28%
• Medications for Opioid Use Disorder 28%
• Face-to-face Counseling 28%
• Cost per Quality-adjusted Life Year 28%
• United States 14%
• COVID-19 14%
• Opioid Epidemic 14%
• Buprenorphine 14%
• Evidence-based 14%
• Abstinence 14%
• Mental Health 14%
• Cost Data 14%
• Physical Health 14%
• Neurobehavior 14%
• Prescription Drugs 14%
• Social Distancing 14%
• Claims Database 14%
• Incremental Cost 14%
• Health Burden 14%
• Decision-analytic Model 14%
• Medical Costs 14%
• Policy Discussion 14%
• Resource Cost 14%
• Clinical Efficacy 14%
• Contingency Management 14%
• Resource Utilization 14%
• Health Costs 14%
• Overall Cost 14%
• Non-drug 14%
• Commercial Use 14%
• Clinical Resources 14%
• Opioid-related Deaths 14%
• Utility Value 14%
• Adjunctive Therapy 14%
• S-states 14%
• Treatment Utility 14%
• Utilization Data 14%
• Life-years Gained 14%
• Real-world Evidence Study 14%
• Population Norms 14%
• Total Health Care Costs 14%

Psychology

• Opioid Abuse 100%
• Opioid 50%
• Healthcare 25%
• Contingency Management 25%
• COVID-19 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Clinical Trial 40%
• Pandemic 20%
• Buprenorphine 20%
• Non Prescription Drug 20%